Financhill
Back

Vertex Pharmaceuticals 10K Form

Buy
63

VRTX
Vertex Pharmaceuticals

Last Price:
351.07
Seasonality Move:
0.68%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive VRTX News And Ratings

See the #1 stock for the next 7 days that we like better than VRTX

VRTX Financial Statistics

Sales & Book Value

Annual Sales: $8.93B
Cash Flow: $1.07B
Price / Cash Flow: 23.55
Annual Sales: $60.01
Price / Book: 5.86

Profitability

EPS (TTM): 12.95000
Net Income (TTM): $3.36B
Gross Margin: $7.85B
Return on Equity: 24.46%
Return on Assets: 18.74%

Vertex Pharmaceuticals Earnings Forecast

Key Vertex Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 32 years for VRTX is 87.90%.
  • The Selling, General & Administrative Expenses for VRTX have been equal to 10.58% of Gross Profit Margin.
  • The Research & Development expenses have been 28.44% of Revenue.
  • The Interest Expense is 1.65% of Operating Income.
  • The Net Earning history of VRTX is 37.20% of Total Revenues.
  • Per Share Earnings over the last 33 years have been positive in 13 years.

Vertex Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Healthcare
Current Symbol: VRTX
CUSIP: 92532F
Website: vrtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 4.14
Quick Ratio: 3.82

Price-to-Earnings

Trailing P/E Ratio: 27.39
Forward P/E Ratio: 21.76

VRTX Technical Analysis vs Fundamental Analysis

Buy
63
Vertex Pharmaceuticals (VRTX) is a Buy

Is Vertex Pharmaceuticals a Buy or a Sell?